Anavex Life Sciences Corp (AVXL)

[nidan7500]

https://finance.yahoo.com/news/anavex-life-sciences-receives-regulatory-110010418.html

NEW YORK, June 04, 2020 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced that it has received a No Objection Letter from Health Canada as well as Clinical Trial Authorization (CTA) from the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom (UK) to expand the Phase 2b/3 double-blind, randomized, placebo-controlled safety and efficacy trial (Study ANAVEX®2-73-AD-004) of ANAVEX®2-73 (blarcamesine) for the treatment of early Alzheimer’s disease into Canada and UK, respectively.
The 48-week Phase 2b/3 study ANAVEX®2-73-AD-004 (ClinicalTrials.gov NCT03790709) of ANAVEX®2-73 (blarcamesine) using biomarker and precision medicine in 450 patients with early Alzheimer’s disease is ongoing and currently over 50% enrolled.
“We are excited to receive the regulatory approvals for this Phase 2b/3 study for patients seeking treatment for Alzheimer’s disease,” commented Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex. “This expansion into North America and Europe should accelerate the completion of the enrollment of the ongoing ANAVEX®2-73-AD-004 Alzheimer’s disease Phase 2b/3 trial with ANAVEX®2-73 (blarcamesine).”

How AB-E-NORMAL an action is this? It certainly seems a smart management effort but is it easily-routinely approved by the regulatory agencies?
Is it a big and unusual process change or is it just a good idea, often done?

Have re-read this and do not find any hidden coded, secret handshake message. (like-OH no, we do this all the time).

Would Canadians and Brits have done this b/c they see gains for their respective countries based on some other A2-73 performance insights?

Just curious when any time a unique process step is taken in regulatory bodies it is usually for a good reason.

Comments on seeing this done before? (when, why, then what happened??)